Milestones in magnetic resonance imaging and transcranial sonography of movement disorders

Movement Disorders

Volumn 26, Issue 6, 2011, Pages 979-992

  Berg, Daniela ^a   Steinberger, Jonathan D ^b   Warren Olanow, C ^c   Naidich, Thomas P ^b   Yousry, Tarek A ^d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Application and limitation; Future perspectives; Magnetic resonance imaging; Movement disorders; Transcranial sonography

Indexed keywords

CEREBELLAR PEDUNCLE; CHOREA MINOR; CORTICOBASAL DEGENERATION; DIFFUSION WEIGHTED IMAGING; DOPPLER ECHOGRAPHY; FRIEDREICH ATAXIA; GILLES DE LA TOURETTE SYNDROME; HUNTINGTON CHOREA; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPSOCLONUS MYOCLONUS SYNDROME; PARKINSON DISEASE; PERIPHERAL BLOOD VESSEL MALFORMATION; PRION DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA; WILSON DISEASE;

EID: 79957606044     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23766     Document Type: Review

References (127)

1. Mahlknecht P, Hotter A, Hussl A, Esterhammer R, Schocke M, Seppi K. Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease. Neurodegener Dis. 2010; 7: 300-318.
2. Draganski B, Bhatia K. Brain structure in movement disorders: a neuroimaging perspective. Curr Opin Neurol. 2010; 23: 413-419.
3. Drayer B, Olanow CW, Burger P, Johnson A, Herfkins R, Riederer S. High field magnetic resonance imaging of brain iron-diagnosis of Parkinson's plus (multi-system atrophy) syndromes. Radiology. 1986; 159: 493-498.
4. Bhattacharya K, Saadia D, Eisenkraft B, et al. Brain magnetic resonance imaging in multiple system atrophy and Parkinson's disease. A diagnostic algorithm. Arch Neurol. 2002; 59: 835-842.
5. Matsusue E, Fujii, S, Kanasaki Y, et al. Putaminal lesion in multiple system atrophy: postmortem MR-pathological correlations. Neuroradiology. 2008; 50: 559-567.
6. Oestreicher E, Sengstock GJ, Riederer P, Olanow CW, Dunn AJ, Arendash G. Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study. Brain Res. 1994; 660: 8-18.
7. Schrag A, Kingsley D, Phatouros C, et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry. 1998; 65: 65-71.
8. Shrivastava A. The hot cross bun sign. Radiology. 2007; 245: 606-607.
9. Horimoto Y, Aiba I, Yasuda T, et al. Longitudinal MRI study of multiple system atrophy-when do the findings appear, and what is the course? J Neurol. 2002; 249: 847-854.
10. Köllensperger M, Wenning G. Assessing disease progression with MRI in atypical parkinsonian disorders. Mov Disord. 2009; 24(Suppl 2): S699-S702.
11. Wannuth-Metz M, Naumann M, Csoti I, Solymosi L. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol. 2001; 58: 1076-1079.
12. Oba H, Yagishita A, Terada H, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology. 2005; 64: 2050-2055.
13. Quattrone A, Nicoletti G, Messina D, et al. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology. 2008; 246: 214-221.
14. Longoni G, Agosta F, Kostić VS, et al. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease. Mov Disord. 2011; 26: 247-255.
15. Hauser RA, Murtaugh FR, Akhter K, Gold M, Olanow CW. Magnetic resonance imaging of cotircobasal degeneration. J Neuroimaging. 1996; 6: 222-226.
16. Bamford K, Caine ED, Kido DK, et al. A prospective evaluation of cognitive decline in early Huntington's disease: functional and radiographic correlates. Neurology. 1995; 45: 1867-1873.
17. Kloppel S, Henley SM, Hobbs NZ, et al. Magnetic resonance imaging of Huntington's disease: preparing for clinical trials. Neuroscience. 2009; 164: 205-219.
18. Stoffers D, Sheldon S, Kuperman JM. Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study. Neurology. 2010; 74: 1208-1216.
19. Sinha S, Taly AB, Ravishankar S, et al. Wilson's disease: cranial MRI observations and clinical correlation. Neuroradiology. 2006; 48: 613-621.
20. Kim TJ, Kim IO, Kim WS, et al. MR Imaging of the brain in Wilson disease of childhood: findings before and after treatment with clinical correlation. Am J Neuroradiol. 2006; 27: 1373-1378.
21. Vital A, Fernagut PO, Canron MH, et al. The nigrostriatal pathway in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol. 2009; 68: 809-815.
22. Maltête D, Guyant-Maréchal L, Mihout B, Hannequin D. Movement disorders and Creutzfeldt-Jakob disease: a review. Parkinsonism Relat Disord. 2006; 12: 65-71.
23. Karacostas D. Neuroimaging in human prion disease: searching in the mist. World J Radiol. 2009; 1: 45-49.
24. Macfarlane RG, Wroe SJ, Collinge J, Yousry TA, Jäger HR. Neuroimaging findings in human prion disease. J Neurol Neurosurg Psychiatry. 2007; 78: 664-670.
25. Robertson WC Jr, Smith C. Sydenham's chorea in the age of MRI: a case report and review. Pediatr Neurol. 2002; 27: 65-67.
26. Oosterveer DM, Overweg-Plandsoen WC, Roos RA. Sydenham's chorea: a practical overview of the current literature. Pediatr Neurol. 2010; 43: 1-6.
27. Plessen KJ, Bansal R, Peterson BS. Imaging evidence for anatomical disturbances and neuroplastic compensation in persons with Tourette syndrome. J Psychosom Res. 2009; 67: 559-573.
28. Draganski B, Martino D, Cavanna A, et al. Multispectral brain morphometry in Tourette syndrome persisting into adulthood. Brain. 2010; 133: 3661-3675.
29. Hayflick SJ, Hartman M, Coryell J, Gitschier J, Rowley H. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. Am J Neuroradiol. 2006; 27: 1230-1233.
30. Olanow CW. Manganese-induced parkinsonism and Parkinson's disease. Ann N Y Acad Sci. 2004; 1012: 209-223.
31. Hauser RA, Zesiewicz TA, Martinez C, Rosemurgy AS, Olanow CW. Manganese intoxication may cause neurologic dysfunction in chronic liver disease. Ann Neurol. 1995; 45: 369.
32. Della Nave R, Ginestroni A, Giannelli M, et al. Brain structural damage in Friedreich's ataxia. J Neurol Neurosurg Psychiatry. 2008; 79: 82-85.
33. Berry-Kravis E, Abrams L, Coffey SM, et al. Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov Disord. 2007; 22: 2018-2030.
34. Jacquemont S, Hagerman RJ, Leehey M, et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet. 2003; 72: 869-878.
35. Brunberg JA, Jacquemont S, Hagerman RJ, et al. Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. Am J Neuroradiol. 2002; 23: 1757-1766.
36. Uchino A, Sawada A, Takase Y, Kudso S. Symmetrical lesions of the middle cerebellar peduncle: MR imaging and differential diagnosis. Magn Reson Med Sci. 2004; 3: 133-140.
37. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology. 1995; 45: 182-184.
38. Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg. 1982; 57: 769-774.
39. Seidel G, Kaps M, Gerriets T. Potential and limitations of transcranial color-coded sonography in stroke patients. Stroke. 1995; 26: 2061-2066.
40. Baumgartner RW, Arnold M, Gonner F, et al. Contrast-enhanced transcranial color-coded duplex sonography in ischemic cerebrovascular disease. Stroke 1997; 28(12): 2473-2478.
41. Kamphuisen HA, Somer JC, Oosterbaan WA. Two-dimensional echoencephalography with electronic sector scanning. Clinical experiences with a new method. J Neurol Neurosurg Psychiatry. 1972; 35: 912-918.
42. Schoning M, Grunert D, Stier B. [Transcranial real-time sonography in children and adolescents, ultrasound anatomy of the brain]. Ultraschall Med. 1988; 9: 286-292.
43. Berland LL, Bryan CR, Sekar BC, Moss CN. Sonographic examination of the adult brain. J Clin Ultrasound. 1988; 16: 337-345.
44. Furuhata H. New evolution of transcranial tomography (TCT) and transcranial color coded Doppler tomography (TCDT). Neurosonology. 1989; 2: 8-15.
45. Becker G, Bogdahn U, Strassburg HM, et al. Identification of ventricular enlargement and estimation of intracranial pressure by transcranial color-coded real-time sonography. J Neuroimaging. 1994; 4: 17-22.
46. Seidel G, Kaps M, Gerriets T, Hutzelmann A. Evaluation of the ventricular system in adults by transcranial duplex sonography. J Neuroimaging. 1995; 5: 105-108.
47. Becker G, Perez J, Krone A, et al. Transcranial color-coded real-time sonography in the evaluation of intracranial neoplasms and arteriovenous malformations. Neurosurgery. 1992; 31: 420-428.
48. Becker G, Krone A, Koulis D, et al. Reliability of transcranial colour-coded real-time sonography in assessment of brain tumours: correlation of ultrasound, computed tomography and biopsy findings. Neuroradiology. 1994; 36: 585-590.
49. Berg D, Siefker C, Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol. 2001; 248: 684-689.
50. Walter U, Wittstock M, Benecke R, Dressler D. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm. 2002; 109: 191-196.
51. Huang YW, Jeng JS, Tsai CF, Chen LL, Wu RM. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease. Mov Disord. 2007; 22: 550-555.
52. Kim JY, Kim ST, Jeon SH, Lee WY. Midbrain transcranial sonography in Korean patients with Parkinson's disease. Mov Disord. 2007; 22: 1922-1926.
53. Okawa M, Miwa H, Kajimoto Y, et al. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations. Intern Med. 2007; 46: 1527-1531.
54. Ressner P, Skoloudik D, Hlustik P, Kanovsky P. Hyperechogenicity of the substantia nigra in Parkinson's disease. J Neuroimaging. 2007; 17: 164-167.
55. Tsai CF, Wu RM, Huang YW, Chen LL, Yip PK, Jeng JS. Transcranial color-coded sonography helps differentiation between idiopathic Parkinson's disease and vascular parkinsonism. J Neurol. 2007; 254: 501-507.
56. Mijajlovic M, Petrovic I, Stojkovic T, Svetel M, Stefanova E, Kostic VS. [Transcranial parenchymal sonography in the diagnosis of Parkinson's disease]. Vojnosanitetski pregled. 2008; 65: 601-605.
57. Budisic M, Trkanjec Z, Bosnjak J, Lovrencic-Huzjan A, Vukovic V, Demarin V. Distinguishing Parkinson's disease and essential tremor with transcranial sonography. Acta Neurol Scand. 2009; 119: 17-21.
58. Berg D, Becker G, Zeiler B, et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology. 1999; 53: 1026-1031.
59. Vlaar AM, Bouwmans A, Mess WH, Tromp SC, Weber WE. Transcranial duplex in the differential diagnosis of parkinsonian syndromes: a systematic review. J Neurol. 2009; 256: 530-538.
60. Godau J, Berg D. Role of transcranial ultrasound in the diagnosis of movement disorders. Neuroimaging Clin N Am. 2010; 20: 87-101.
61. Berg D. Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease. J Neural Transm. 2011; 118: 453-461.
62. Berg D, Behnke S, Walter U. Application of transcranial sonography in extrapyramidal disorders: updated recommendations. Ultraschall Med. 2006; 27: 12-19.
63. Berg D, Godau J, Walter U. Transcranial sonography in movement disorders. Lancet Neurol. 2008; 7: 1044-1055.
64. Walter U, Behnke S, Eyding J, et al. Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med Biol. 2007; 33: 15-25.
65. Berg D, Jabs B, Merschdorf U, Beckmann H, Becker G. Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry. 2001; 50: 463-467.
66. Spiegel J, Hellwig D, Mollers MO, et al. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain. 2006; 129: 1188-1193.
67. Walter U, Dressler D, Wolters A, Wittstock M, Benecke R. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease. Mov Disord. 2007; 22: 48-54.
68. Berg D, Merz B, Reiners K, Naumann M, Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord. 2005; 20: 383-385.
69. Kolevski G, Petrov I, Petrova V. Transcranial sonography in the evaluation of Parkinson disease. J Ultrasound Med. 2007; 26: 509-512.
70. Weise D, Lorenz R, Schliesser M, Schirbel A, Reiners K, Classen J. Substantia nigra echogenicity: a structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease. Mov Disord. 2009; 24: 1669-1675.
71. Walter U, Krolikowski K, Tarnacka B, Benecke R, Czlonkowska A, Dressler D. Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology. 2005; 64: 1726-1732.
72. Walter U, Kanowski M, Kaufmann J, Grossmann A, Benecke R, Niehaus L. Contemporary ultrasound systems allow high-resolution transcranial imaging of small echogenic deep intracranial structures similarly as MRI: a phantom study. Neuroimage. 2008; 40: 551-558.
73. Krogias C, Meves S, Schoellhammer M, Gold R, Andrich J. Sonographic detection of bilateral striopallidodentate calcinosis. J Neurol. 2009; 256: 266-267.
74. Venegas-Francke P. Transcranial sonography in the discrimination of Parkinson's disease versus vascular parkinsonism. Int Rev Neurobiol. 2010; 90: 147-156.
75. Becker G, Struck M, Bogdahn U, Becker T. Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Res. 1994; 55: 75-84.
76. Berg D, Supprian T, Hofmann E, et al. Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol. 1999; 246: 1186-1193.
77. Mijajlovic MD. Transcranial sonography in depression. Int Rev Neurobiol. 2010; 90: 259-272.
78. Stockner H, Sojer M, K KS, et al. Midbrain sonography in patients with essential tremor. Mov Disord. 2007; 22: 414-417.
79. Stockner H, Wurster I. Transcranial sonography in essential tremor. Int Rev Neurobiol. 2010; 90: 189-197.
80. Bouwmans AE, Vlaar AM, Srulijes K, Mess WH, Weber WE. Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes. Int Rev Neurobiol. 2010; 90: 121-146.
81. Walter U, Dressler D, Wolters A, Wittstock M, Greim B, Benecke R. Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia. J Neurol. 2006; 253: 448-454.
82. Walter U, Dressler D, Wolters A, Probst T, Grossmann A, Benecke R. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology. 2004; 63: 504-509.
83. Prestel J, Schweitzer KJ, Hofer A, Gasser T, Berg D. Predictive value of transcranial sonography in the diagnosis of Parkinson's disease. Mov Disord. 2006; 21: 1763-1765.
84. van de Loo S, Walter U, Behnke S, et al. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2010; 81: 1087-1092.
85. Gaenslen A, Unmuth B, Godau J, et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol. 2008; 7: 417-424.
86. Berg D, Roggendorf W, Schroder U, et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol. 2002; 59: 999-1005.
87. Behnke S, Double KL, Duma S, et al. Substantia nigra echomorphology in the healthy very old: correlation with motor slowing. Neuroimage. 2007; 34: 1054-1059.
88. Liepelt I, Behnke S, Schweitzer K, et al. Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population. Neurobiol Aging. 2009 [Epub ahead of print].
89. Ruprecht-Dorfler P, Berg D, Tucha O, et al. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. Neuroimage. 2003; 18: 416-422.
90. Schweitzer KJ, Behnke S, Liepelt I, et al. Cross-sectional study discloses a positive family history for Parkinson's disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity. J Neural Transm. 2007; 114: 1167-1171.
91. Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H. Olfactory loss may be a first sign of idiopathic Parkinson's disease. Mov Disord. 2007; 22: 839-842.
92. Walter U, Hoeppner J, Prudente-Morrissey L, Horowski S, Herpertz SC, Benecke R. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain. 2007; 130: 1799-1807.
93. Liepelt I, Wendt A, Schweitzer KJ, et al. Substantia nigra hyperechogenicity assessed by transcranial sonography is related to neuropsychological impairment in the elderly population. J Neural Transm. 2008; 115: 993-999.
94. Stockner H, Iranzo A, Seppi K, et al. Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder. Mov Disord. 2009; 24: 1906-1909.
95. Unger MM, Moller JC, Ohletz T, Stiasny-Kolster K, Oertel WH, Mayer G. Transcranial midbrain sonography in narcoleptic subjects with and without concomitant REM sleep behaviour disorder. J Neurol. 2009; 256: 874-877.
96. Walter U, Klein C, Hilker R, Benecke R, Pramstaller PP, Dressler D. Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord. 2004; 19: 1445-1449.
97. * Brain. 2005; 128: 3000-3011.
98. Schweitzer KJ, Brussel T, Leitner P, et al. Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease. J Neurol. 2007; 254: 613-616.
99. Hagenah JM, Konig IR, Becker B, et al. Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles. J Neurol. 2007; 254: 1407-1413.
100. Hagenah JM, Becker B, Bruggemann N, et al. Transcranial sonography findings in a large family with homozygous and heterozygous PINK1 mutations. J Neurol Neurosurg Psychiatry. 2008; 79: 1071-1074.
101. Brockmann K, Hagenah J. TCS in monogenic forms of Parkinson's disease. Int Rev Neurobiol. 2010; 90: 157-164.
102. Berg D, Grote C, Rausch WD, et al. Iron accumulation in the substantia nigra in rats visualized by ultrasound. Ultrasound Med Biol. 1999; 25: 901-904.
103. Sofic E, Riederer P, Heinsen H, et al. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm. 1988; 74: 199-205.
104. Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MB. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem, 1991; 56: 978-982.
105. Riederer P, Sofic E, Rausch WD, et al. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem, 1989; 52: 515-520.
106. Schmidauer C, Sojer M, Seppi K, et al. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol. 2005; 58: 630-634.
107. Godau J, Klose U, Di Santo A, Schweitzer K, Berg D. Multiregional brain iron deficiency in restless legs syndrome. Mov Disord. 2008; 23: 1184-1187.
108. Berg D, Godau J, Riederer P, Gerlach M, Arzberger T. Microglia activation is related to substantia nigra echogenicity. J Neural Transm. 2010; 117: 1287-1292.
109. Felletschin B, Bauer P, Walter U, et al. Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra. Neurosci Lett. 2003; 352: 53-56.
110. Deplazes J, Schobel K, Hochstrasser H, et al. Screening for mutations of the IRP2 gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra. J Neural Transm. 2004; 111: 515-521.
111. Hochstrasser H, Bauer P, Walter U, et al. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology. 2004; 63: 1912-1917.
112. Berg D, Hochstrasser H, Schweitzer KJ, Riess O. Disturbance of iron metabolism in Parkinson's disease-ultrasonography as a biomarker. Neurotox Res. 2006; 9: 1-13.
113. Akbas N, Hochstrasser H, Deplazes J, et al. Screening for mutations of the HFE gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra. Neurosci Lett. 2006; 407: 16-19.
114. Naumann M, Becker G, Toyka KV, Supprian T, Reiners K. Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology. 1996; 47: 1284-1290.
115. Becker G, Naumann M, Scheubeck M, et al. Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis. Mov Disord. 1997; 12: 79-88.
116. Becker G, Berg D, Kruse N, et al. Evidence for shoulder girdle dystonia in selected patients with cervical disc prolapse. Mov Disord. 2002; 17: 710-716.
117. Becker G, Berg D, Rausch WD, Lange HK, Riederer P, Reiners K. Increased tissue copper and manganese content in the lentiform nucleus in primary adult-onset dystonia. Ann Neurol. 1999; 46: 260-263.
118. Berg D, Weishaupt A, Francis MJ, et al. Changes of copper-transporting proteins and ceruloplasmin in the lentiform nuclei in primary adult-onset dystonia. Ann Neurol. 2000; 47: 827-830.
119. Kruse N, Berg D, Francis MJ, et al. Reduction of Menkes mRNA and copper in leukocytes of patients with primary adult-onset dystonia. Ann Neurol. 2001; 49: 405-408.
120. Krogias C, Postert T, Eyding J. Transcranial sonography in ataxia. Int Rev Neurobiol. 2010; 90: 217-235.
121. Krogias C, Eyding J, Postert T. Transcranial sonography in Huntington's disease. Int Rev Neurobiol. 2010; 90: 237-257.
122. Godau J, Sojer M. Transcranial sonography in restless legs syndrome. Int Rev Neurobiol. 2010; 90: 199-215.
123. Walter U. Transcranial sonography in brain disorders with trace metal accumulation. Int Rev Neurobiol. 2010; 90: 166-178.
124. Berg D, Walter U, eds. Transcranial Sonography in Movement Disorders. New York: Academic Press; 2010.
125. Moringlane JR, Fuss G, Becker G. Peroperative transcranial sonography for electrode placement into the targeted subthalamic nucleus of patients with Parkinson disease: technical note. Surg Neurol. 2005; 63: 66-69; discussion 69.
126. Walter U, Wolters A, Wittstock M, Benecke R, Schroeder HW, Muller JU. Deep brain stimulation in dystonia: sonographic monitoring of electrode placement into the globus pallidus internus. Mov Disord. 2009; 24: 1538-1541.
127. White PJ, Whalen S, Tang SC, Clement GT, Jolesz F, Golby AJ. An intraoperative brain shift monitor using shear mode transcranial ultrasound: preliminary results. J Ultrasound Med. 2009; 28: 191-203.